Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Long-Term Investments (2020 - 2021)

Historic Long-Term Investments for Tango Therapeutics (TNGX) over the last 2 years, with Q2 2021 value amounting to $166.8 million.

  • Tango Therapeutics' Long-Term Investments changed N/A to $166.8 million in Q2 2021 from the same period last year, while for Jun 2021 it was $166.8 million, marking a year-over-year change of. This contributed to the annual value of $166.8 million for FY2020, which is N/A changed from last year.
  • Per Tango Therapeutics' latest filing, its Long-Term Investments stood at $166.8 million for Q2 2021.
  • In the past 5 years, Tango Therapeutics' Long-Term Investments registered a high of $166.8 million during Q4 2020, and its lowest value of $166.8 million during Q3 2020.